RJA
MDT icon

Ross\Johnson & Associates’s Medtronic MDT Stock Holding History

Ross\Johnson & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.6K Sell
238
-1
-0.4% -$96 0.37% 26
2025
Q4 		$23K Sell
239
-1
-0.4% -$97 0.43% 25
2025
Q3 		$22.9K Hold
240
– – 0.43% 24
2025
Q2 		$20.9K Sell
240
-90
-27% -$7.63K 0.43% 23
2025
Q1 		$29.7K Hold
330
– – 0.51% 28
2024
Q4 		$26.4K Buy
+330
New +$28.6K 0.61% 18

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ross\Johnson & Associates's MDT Position: Q1 2026 in Review

Ross\Johnson & Associates reduced its Medtronic (MDT) stake by 0.42% in Q1 2026, selling an estimated $96 and leaving 238 shares worth $20.6K. The position accounts for 0.37% of the portfolio, ranked #26.

Ross\Johnson & Associates first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. The position peaked at $29.7K in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Ross\Johnson & Associates held 238 shares of Medtronic worth $20.6K as of Q1 2026.
  • Ross\Johnson & Associates sold 1 Medtronic share in Q1 2026, an estimated $96.
  • Medtronic made up 0.37% of Ross\Johnson & Associates's portfolio in Q1 2026, its #26 holding.
  • Ross\Johnson & Associates first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • Ross\Johnson & Associates's Medtronic position peaked at $29.7K in Q1 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.